{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T17:05:10Z","timestamp":1789578310363,"version":"build-2803163510"},"reference-count":37,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","euoncology.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Oncology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.euo.2026.05.006","type":"journal-article","created":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T05:37:53Z","timestamp":1780119473000},"page":"883-894","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["AI-MIRACLE: Artificial Intelligence and MultIpaRAmetric MRI Predict CLinical OutcomEs to Neoadjuvant Immunotherapy in Patients with Muscle-invasive Bladder Cancer Undergoing Radical Cystectomy"],"prefix":"10.1016","volume":"9","author":[{"given":"Andrea","family":"Necchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Brembilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karissa","family":"Whiting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Arita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oguz","family":"Akin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditya","family":"Apte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Awais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Lema-Dopico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramesh","family":"Paudyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Cosenza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigida Anna","family":"Maiorano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Tateo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Cigliola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Mercinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"De Cobelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marinela","family":"Capanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7456-3197","authenticated-orcid":false,"given":"Amita","family":"Shukla-Dave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence H.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euo.2026.05.006_b0005","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1200\/JCO.18.01148","article-title":"Pembrolizumab as neoadjuvant therapy before radical cystectomy in patients with muscle-invasive urothelial bladder carcinoma (PURE-01): an open-label, single-arm, phase II study","volume":"36","author":"Necchi","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euo.2026.05.006_b0010","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.35601","article-title":"Efficacy and safety of pembrolizumab in patients with advanced urothelial carcinoma deemed potentially ineligible for platinum-containing chemotherapy: post hoc analysis of KEYNOTE-052 and LEAP-011","volume":"131","author":"O\u2019Donnell","year":"2025","journal-title":"Cancer"},{"key":"10.1016\/j.euo.2026.05.006_b0015","series-title":"European Association of Urology guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2025 guidelines","author":"van der Heijden","year":"2025"},{"key":"10.1016\/j.euo.2026.05.006_b0020","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.21037\/tau.2020.02.01","article-title":"Health-related quality of life after radical cystectomy","volume":"9","author":"Choi","year":"2020","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.euo.2026.05.006_b0025","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1038\/s41591-023-02568-1","article-title":"Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial","volume":"29","author":"Galsky","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/j.euo.2026.05.006_b0030","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1200\/JCO-24-01214","article-title":"Phase II trial of risk-enabled therapy after neoadjuvant chemotherapy for muscle-invasive bladder cancer (RETAIN 1)","volume":"43","author":"Geynisman","year":"2025","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euo.2026.05.006_b0035","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.1215","article-title":"Significance of PD-L1 in metastatic urothelial carcinoma treated with immune checkpoint inhibitors: A systematic review and meta-analysis","volume":"7","author":"Maiorano","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.euo.2026.05.006_b0040","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13244-024-01884-5","article-title":"Multiparametric MRI and artificial intelligence in predicting and monitoring treatment response in bladder cancer","volume":"16","author":"Arita","year":"2025","journal-title":"Insights Imaging"},{"key":"10.1016\/j.euo.2026.05.006_b0045","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1007\/s00261-022-03455-y","article-title":"Muscle-invasive bladder cancer: pretreatment prediction of response to neoadjuvant chemotherapy with diffusion-weighted MR imaging","volume":"47","author":"Zhang","year":"2022","journal-title":"Abdom Radiol"},{"key":"10.1016\/j.euo.2026.05.006_b0050","article-title":"Development of a MRI-based radiomics nomogram for prediction of response of patients with muscle-invasive bladder cancer to neoadjuvant chemotherapy","volume":"12","author":"Zhang","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.euo.2026.05.006_b0055","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.eururo.2019.12.016","article-title":"Multiparametric magnetic resonance imaging as a noninvasive assessment of tumor response to neoadjuvant pembrolizumab in muscle-invasive bladder cancer: preliminary findings from the PURE-01 study","volume":"77","author":"Necchi","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2026.05.006_b0060","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.233020","article-title":"Neoadjuvant chemotherapy VI-RADS scores for assessing muscle-invasive bladder cancer response to neoadjuvant immunotherapy with multiparametric MRI","volume":"313","author":"Brembilla","year":"2024","journal-title":"Radiology"},{"key":"10.1016\/j.euo.2026.05.006_b0065","doi-asserted-by":"crossref","first-page":"8821","DOI":"10.1007\/s00330-023-09960-y","article-title":"A machine learning model based on MRI for the preoperative prediction of bladder cancer invasion depth","volume":"33","author":"Chen","year":"2023","journal-title":"Eur Radiol"},{"key":"10.1016\/j.euo.2026.05.006_b0070","article-title":"Deep learning in bladder cancer imaging: a review","volume":"12","author":"Li","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.euo.2026.05.006_b0075","doi-asserted-by":"crossref","first-page":"5107","DOI":"10.1158\/1078-0432.CCR-22-2158","article-title":"Neoadjuvant pembrolizumab and radical cystectomy in patients with muscle-invasive urothelial bladder cancer: 3-year median follow-up update of PURE-01 trial","volume":"28","author":"Basile","year":"2022","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.euo.2026.05.006_b0080","article-title":"Artificial intelligence apps for medical image analysis using pyCERR and cancer genomics cloud","author":"Apte","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.euo.2026.05.006_bib181","doi-asserted-by":"crossref","unstructured":"Awais M, Paudyal R, Akin O, Gold S, Chahwan S, Nincevic J, Ruby L, Bochner BH, Rosenberg J, Aggen D, Al-Ahmadie H, Goh AC, Schwartz LH, Shukla-Dave A. AI-BLADE toolbox: AI-powered BLADdEr multiparametric MRI analysis for clinical application. BJR Artif Intell. 2026 Jan 22;3(1):ubag002. doi: 10.1093\/bjrai\/ubag002. PMID: 42063600; PMCID: PMC13045516.","DOI":"10.1093\/bjrai\/ubag002"},{"key":"10.1016\/j.euo.2026.05.006_b0085","first-page":"3541","article-title":"Bias field correction and intensity normalisation for quantitative analysis of apparent fibre density","volume":"2017","author":"Raffelt","year":"2017","journal-title":"Proc Intl Soc Mag Reson Med"},{"key":"10.1016\/j.euo.2026.05.006_b0090","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.1002\/mp.13046","article-title":"Technical Note: extension of CERR for computational radiomics: A comprehensive MATLAB platform for reproducible radiomics research","volume":"45","author":"Apte","year":"2018","journal-title":"Med Phys"},{"key":"10.1016\/j.euo.2026.05.006_b0095","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1148\/radiol.2020191145","article-title":"The image biomarker standardization initiative: standardized quantitative radiomics for high-throughput image-based phenotyping","volume":"295","author":"Zwanenburg","year":"2020","journal-title":"Radiology"},{"key":"10.1016\/j.euo.2026.05.006_b0100","article-title":"Very deep convolutional networks for large-scale image recognition","author":"Simonyan","year":"2014","journal-title":"arXiv"},{"key":"10.1016\/j.euo.2026.05.006_b0105","article-title":"A multi-patch-based deep learning model with VGG19 for breast cancer classifications in the pathology images","volume":"11","author":"Ponraj","year":"2025","journal-title":"Digit Health"},{"key":"10.1016\/j.euo.2026.05.006_b0110","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1186\/s13104-020-05343-4","article-title":"Can pre-trained convolutional neural networks be directly used as a feature extractor for video-based neonatal sleep and wake classification?","volume":"13","author":"Awais","year":"2020","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.euo.2026.05.006_b0115","series-title":"2017 IEEE International Conference on Signal and Image Processing Applications (ICSIPA)","first-page":"489","article-title":"Classification of SD-OCT images using a Deep learning approach","author":"Awais","year":"2017"},{"key":"10.1016\/j.euo.2026.05.006_b0120","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S","article-title":"Estimating kinetic parameters from dynamic contrast-enhanced t1-weighted MRI of a diffusable tracer: standardized quantities and symbols","volume":"10","author":"Tofts","year":"1999","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.euo.2026.05.006_b0125","series-title":"2022 IEEE International Conference on Systems, Man, and Cybernetics (SMC)","first-page":"3286","article-title":"Improving data stream classification using incremental Yeo-Johnson Power transformation","author":"Tieppo","year":"2022"},{"key":"10.1016\/j.euo.2026.05.006_b0130","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40364-024-00560-6","article-title":"MRI-derived radiomics assessing tumor-infiltrating macrophages enable prediction of immune-phenotype, immunotherapy response and survival in glioma","volume":"12","author":"Chen","year":"2024","journal-title":"Biomark Res"},{"key":"10.1016\/j.euo.2026.05.006_b0135","article-title":"Can only the shape feature in radiomics help machine learning show that bladder cancer has invaded muscles?","volume":"15","author":"\u00d6zdemir","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.euo.2026.05.006_b0140","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/j.ejrad.2013.08.008","article-title":"Dynamic contrast-enhanced MRI in patients with muscle-invasive transitional cell carcinoma of the bladder can distinguish between residual tumour and post-chemotherapy effect","volume":"82","author":"Donaldson","year":"2013","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.euo.2026.05.006_b0145","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.ejrad.2015.02.026","article-title":"Dynamic contrast enhanced MRI-derived parameters are potential biomarkers of therapeutic response in bladder carcinoma","volume":"84","author":"Chakiba","year":"2015","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.euo.2026.05.006_b0150","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1038\/s41467-023-37568-9","article-title":"Expression-based subtypes define pathologic response to neoadjuvant immune-checkpoint inhibitors in muscle-invasive bladder cancer","volume":"14","author":"Robertson","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.euo.2026.05.006_b0155","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.eururo.2021.03.014","article-title":"Molecular characterization of residual bladder cancer after neoadjuvant pembrolizumab","volume":"80","author":"Necchi","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2026.05.006_b0160","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.compbiomed.2019.04.018","article-title":"Deep learning for identifying radiogenomic associations in breast cancer","volume":"109","author":"Zhu","year":"2019","journal-title":"Comput Biol Med"},{"key":"10.1016\/j.euo.2026.05.006_b0165","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.3390\/s21062222","article-title":"MRI-based brain tumor classification using ensemble of deep features and machine learning classifiers","volume":"21","author":"Kang","year":"2021","journal-title":"Sensors"},{"key":"10.1016\/j.euo.2026.05.006_b0170","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3390\/bioengineering11050472","article-title":"Preoperative molecular subtype classification prediction of ovarian cancer based on multi-parametric magnetic resonance imaging multi-sequence feature fusion network","volume":"11","author":"Du","year":"2024","journal-title":"Bioengineering"},{"key":"10.1016\/j.euo.2026.05.006_b0175","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.3390\/diagnostics13203266","article-title":"Deep features from pretrained networks do not outperform hand-crafted features in radiomics","volume":"13","author":"Demircio\u011flu","year":"2023","journal-title":"Diagnostics"},{"key":"10.1016\/j.euo.2026.05.006_b0180","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s13244-022-01328-y","article-title":"Predictive performance of radiomic models based on features extracted from pretrained deep networks","volume":"13","author":"Demircio\u011flu","year":"2022","journal-title":"Insights Imaging"}],"container-title":["European Urology Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931126001331?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931126001331?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T16:45:48Z","timestamp":1789577148000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2588931126001331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2588931126001331"],"URL":"https:\/\/doi.org\/10.1016\/j.euo.2026.05.006","relation":{},"ISSN":["2588-9311"],"issn-type":[{"value":"2588-9311","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AI-MIRACLE: Artificial Intelligence and MultIpaRAmetric MRI Predict CLinical OutcomEs to Neoadjuvant Immunotherapy in Patients with Muscle-invasive Bladder Cancer Undergoing Radical Cystectomy","name":"articletitle","label":"Article Title"},{"value":"European Urology Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euo.2026.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of European Association of Urology.","name":"copyright","label":"Copyright"}]}}